Cargando…

Discovery and structural characterization of monkeypox virus methyltransferase VP39 inhibitors reveal similarities to SARS-CoV-2 nsp14 methyltransferase

Monkeypox is a disease with pandemic potential. It is caused by the monkeypox virus (MPXV), a double-stranded DNA virus from the Poxviridae family, that replicates in the cytoplasm and must encode for its own RNA processing machinery including the capping machinery. Here, we present crystal structur...

Descripción completa

Detalles Bibliográficos
Autores principales: Silhan, Jan, Klima, Martin, Otava, Tomas, Skvara, Petr, Chalupska, Dominika, Chalupsky, Karel, Kozic, Jan, Nencka, Radim, Boura, Evzen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10116469/
https://www.ncbi.nlm.nih.gov/pubmed/37080993
http://dx.doi.org/10.1038/s41467-023-38019-1
_version_ 1785028430584086528
author Silhan, Jan
Klima, Martin
Otava, Tomas
Skvara, Petr
Chalupska, Dominika
Chalupsky, Karel
Kozic, Jan
Nencka, Radim
Boura, Evzen
author_facet Silhan, Jan
Klima, Martin
Otava, Tomas
Skvara, Petr
Chalupska, Dominika
Chalupsky, Karel
Kozic, Jan
Nencka, Radim
Boura, Evzen
author_sort Silhan, Jan
collection PubMed
description Monkeypox is a disease with pandemic potential. It is caused by the monkeypox virus (MPXV), a double-stranded DNA virus from the Poxviridae family, that replicates in the cytoplasm and must encode for its own RNA processing machinery including the capping machinery. Here, we present crystal structures of its 2′-O-RNA methyltransferase (MTase) VP39 in complex with the pan-MTase inhibitor sinefungin and a series of inhibitors that were discovered based on it. A comparison of this 2′-O-RNA MTase with enzymes from unrelated single-stranded RNA viruses (SARS-CoV-2 and Zika) reveals a conserved sinefungin binding mode, implicating that a single inhibitor could be used against unrelated viral families. Indeed, several of our inhibitors such as TO507 also inhibit the coronaviral nsp14 MTase.
format Online
Article
Text
id pubmed-10116469
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-101164692023-04-22 Discovery and structural characterization of monkeypox virus methyltransferase VP39 inhibitors reveal similarities to SARS-CoV-2 nsp14 methyltransferase Silhan, Jan Klima, Martin Otava, Tomas Skvara, Petr Chalupska, Dominika Chalupsky, Karel Kozic, Jan Nencka, Radim Boura, Evzen Nat Commun Article Monkeypox is a disease with pandemic potential. It is caused by the monkeypox virus (MPXV), a double-stranded DNA virus from the Poxviridae family, that replicates in the cytoplasm and must encode for its own RNA processing machinery including the capping machinery. Here, we present crystal structures of its 2′-O-RNA methyltransferase (MTase) VP39 in complex with the pan-MTase inhibitor sinefungin and a series of inhibitors that were discovered based on it. A comparison of this 2′-O-RNA MTase with enzymes from unrelated single-stranded RNA viruses (SARS-CoV-2 and Zika) reveals a conserved sinefungin binding mode, implicating that a single inhibitor could be used against unrelated viral families. Indeed, several of our inhibitors such as TO507 also inhibit the coronaviral nsp14 MTase. Nature Publishing Group UK 2023-04-20 /pmc/articles/PMC10116469/ /pubmed/37080993 http://dx.doi.org/10.1038/s41467-023-38019-1 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Silhan, Jan
Klima, Martin
Otava, Tomas
Skvara, Petr
Chalupska, Dominika
Chalupsky, Karel
Kozic, Jan
Nencka, Radim
Boura, Evzen
Discovery and structural characterization of monkeypox virus methyltransferase VP39 inhibitors reveal similarities to SARS-CoV-2 nsp14 methyltransferase
title Discovery and structural characterization of monkeypox virus methyltransferase VP39 inhibitors reveal similarities to SARS-CoV-2 nsp14 methyltransferase
title_full Discovery and structural characterization of monkeypox virus methyltransferase VP39 inhibitors reveal similarities to SARS-CoV-2 nsp14 methyltransferase
title_fullStr Discovery and structural characterization of monkeypox virus methyltransferase VP39 inhibitors reveal similarities to SARS-CoV-2 nsp14 methyltransferase
title_full_unstemmed Discovery and structural characterization of monkeypox virus methyltransferase VP39 inhibitors reveal similarities to SARS-CoV-2 nsp14 methyltransferase
title_short Discovery and structural characterization of monkeypox virus methyltransferase VP39 inhibitors reveal similarities to SARS-CoV-2 nsp14 methyltransferase
title_sort discovery and structural characterization of monkeypox virus methyltransferase vp39 inhibitors reveal similarities to sars-cov-2 nsp14 methyltransferase
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10116469/
https://www.ncbi.nlm.nih.gov/pubmed/37080993
http://dx.doi.org/10.1038/s41467-023-38019-1
work_keys_str_mv AT silhanjan discoveryandstructuralcharacterizationofmonkeypoxvirusmethyltransferasevp39inhibitorsrevealsimilaritiestosarscov2nsp14methyltransferase
AT klimamartin discoveryandstructuralcharacterizationofmonkeypoxvirusmethyltransferasevp39inhibitorsrevealsimilaritiestosarscov2nsp14methyltransferase
AT otavatomas discoveryandstructuralcharacterizationofmonkeypoxvirusmethyltransferasevp39inhibitorsrevealsimilaritiestosarscov2nsp14methyltransferase
AT skvarapetr discoveryandstructuralcharacterizationofmonkeypoxvirusmethyltransferasevp39inhibitorsrevealsimilaritiestosarscov2nsp14methyltransferase
AT chalupskadominika discoveryandstructuralcharacterizationofmonkeypoxvirusmethyltransferasevp39inhibitorsrevealsimilaritiestosarscov2nsp14methyltransferase
AT chalupskykarel discoveryandstructuralcharacterizationofmonkeypoxvirusmethyltransferasevp39inhibitorsrevealsimilaritiestosarscov2nsp14methyltransferase
AT kozicjan discoveryandstructuralcharacterizationofmonkeypoxvirusmethyltransferasevp39inhibitorsrevealsimilaritiestosarscov2nsp14methyltransferase
AT nenckaradim discoveryandstructuralcharacterizationofmonkeypoxvirusmethyltransferasevp39inhibitorsrevealsimilaritiestosarscov2nsp14methyltransferase
AT bouraevzen discoveryandstructuralcharacterizationofmonkeypoxvirusmethyltransferasevp39inhibitorsrevealsimilaritiestosarscov2nsp14methyltransferase